WHO analysis of causes of maternal death: a systematic reviewKhalid S. Khan, Paul FA Van Look, Daniel Wojdyla et al.|The Lancet|2006Cited by 4k
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A.A. Fox, Robert M. Califf, Graeme J. Hankey et al.|European Heart Journal|2011Cited by 614
The association between triglycerides and incident cardiovascular disease: What is “optimal”?Tsion Aberra, Ann Marie Návar, Eric D. Peterson et al.|Journal of clinical lipidology|2020Cited by 119
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKDDaniel Edmonston, Daniel Wojdyla, Rupal Mehta et al.|American Journal of Kidney Diseases|2019Cited by 16